BUY Concord Biotech Limited — Ansh Jogendra Bhilwar
byAnsh Jogendra BhilwarHorizon: NA (inferred 1 year)2 Sept 2026via Zee Business (Live)
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Market Trading Guide: Hindustan Copper among 2 stock recommendations for Tuesday
NewsEt-Markets·17 Aug · 2w ago
1 advisor has an active short-term BUY call on this stock
Advisor consensus · adjacent horizon·30 Jul · 1mo ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Concord Biotech
- BUY — Siddharth Rai Mangala21 Sept 2026 · ~1 year · target ₹1,750 · SL hit
- BUY — IDBI Capital21 Sept 2026 · ~3 months · target ₹1,685 · SL hit
- BUY — Sachin Janardan Sarvade, IDBI Capital Markets and Securities15 Sept 2026 · ~2 weeks · target ₹1,717 · SL hit
- BUY — Sumeet Bagadia, Choice Broking18 Aug 2026 · ~2 weeks · target ₹1,650 · Expired
- BUY — Osho Krishan, Angel One4 Aug 2026 · ~2 weeks · target ₹1,550 · Expired
More from Ansh Jogendra Bhilwar
- BUY Indus Towers9 Oct 2026 · ~2 weeks · target ₹385 · Active
- BUY Tata Consultancy Services9 Oct 2026 · ~1 year · target ₹2,300 · Active
- BUY Eicher Motors9 Oct 2026 · ~2 weeks · target ₹6,952 · Target hit
- BUY Lemon Tree Hotels9 Oct 2026 · Same day · target ₹113 · Expired
- BUY BSE8 Oct 2026 · ~3 months · target ₹3,671 · Active

